Dogwood Therapeutics (NASDAQ:DWTX) Trading Up 15.6% – Here’s What Happened

Shares of Dogwood Therapeutics, Inc. (NASDAQ:DWTX) were up 15.6% during trading on Thursday . The stock traded as high as $7.16 and last traded at $6.83. Approximately 218,034 shares traded hands during trading, a decline of 89% from the average daily volume of 2,020,999 shares. The stock had previously closed at $5.91.

Dogwood Therapeutics Price Performance

The stock has a market cap of $9.10 million, a PE ratio of -1.04 and a beta of 2.07. The firm’s 50-day simple moving average is $7.20.

Institutional Trading of Dogwood Therapeutics

A hedge fund recently bought a new stake in Dogwood Therapeutics stock. Geode Capital Management LLC acquired a new stake in shares of Dogwood Therapeutics, Inc. (NASDAQ:DWTX) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 10,933 shares of the company’s stock, valued at approximately $27,000. Geode Capital Management LLC owned 0.82% of Dogwood Therapeutics at the end of the most recent reporting period. Hedge funds and other institutional investors own 9.05% of the company’s stock.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.